Point of Care Diagnostics Market Report by Products, Technology, Point of prescription, End-User, Countries and Company Analysis 2026-2034

Point of Care Diagnostics Market Size and Forecast 2026-2034

The Point of Care Diagnostics Market will expand from US$ 50.41 Billion in 2025 to US$ 100.94 Billion in 2034, at a Compound Annual Growth Rate (CAGR) of 8.02% from 2026-2034. This is due to the increasing demand for rapid diagnostic solutions, the growing number of infectious and chronic diseases, and the increasing use of Point of Care Diagnostics in home healthcare. Advances in technology, portable diagnostic solutions, and increased accessibility in remote areas also contribute to the growth of the Point of Care Diagnostics Market.

Point of Care Diagnostics Industry Overview

Point of Care Diagnostics (POC Diagnostics) is a medical testing process that takes place at or near the location of the patient, like in hospitals, clinics, doctor's offices, ambulances, or even at home. Unlike the traditional lab testing process, where samples are sent to a central lab for testing, POC diagnostics allow patients to get results in a matter of minutes. These tests involve the use of portable and user-friendly devices that can test for a variety of diseases, including infections, chronic diseases, and metabolic disorders. Examples of such tests include blood glucose testing, pregnancy tests, rapid COVID-19 tests, and cardiac marker tests.

The use of POC diagnostics is becoming more popular all over the world because of its ability to provide quick and accurate results, allowing for quicker clinical decision-making and treatment. It also increases patient convenience by reducing waiting times and reducing the need for hospital visits. POC diagnostics are especially important during emergencies, in rural areas, or in developing countries where lab facilities may be limited. Advances in technology, the growing need for home healthcare, and the rising incidence of chronic and infectious diseases are driving the global adoption of POC diagnostics.

Growth Drivers of the Point of Care Diagnostics Market

Rising Prevalence of Chronic and Infectious Diseases

According to a report published by the CDC, congenital heart defects were the most common birth defects in the U.S., affecting about 1% of births each year. Early detection of genetic variations through prenatal testing can help in rapid disease diagnosis, prevention, and selection of appropriate treatment. An increase in lifestyle and environmental changes is rising the incidence of genetic diseases. The incidence of breast and ovarian cancers is rising in many areas. For example, according to the Breast Cancer Research Foundation, in 2023, about 300,590 people are expected to be diagnosed with breast cancer in the U.S. Therefore, the rising incidence of many diseases is expected to fuel the market during the forecast period. The rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory diseases is a key driver of the Point of Care (POC) diagnostics market. These diseases need to be constantly monitored and diagnosed in time to prevent complications and improve patient outcomes. POC diagnostic devices allow for rapid testing and instant results, which help healthcare professionals make immediate treatment decisions. In addition, the rising cases of infectious diseases such as influenza, COVID-19, and other viral and bacterial infections have boosted the demand for rapid diagnostic solutions. POC testing assists in the early diagnosis and prevention of the spread of the disease. The rising geriatric population across the globe is also contributing to the increased burden of diseases, thereby fueling the demand for convenient and frequent testing. With the emphasis on early diagnosis, disease prevention, and efficient management, the demand for rapid and accurate POC diagnostic solutions is on the rise.

Technological Advancements and Portable Diagnostic Devices

Advancements in diagnostic technology have improved the efficiency and accuracy of POC diagnostic devices. Contemporary devices are portable, easy to use, and able to provide highly accurate results in a matter of minutes. Advances in biosensors, microfluidics, and digital health technology have improved testing capabilities, allowing for the simultaneous diagnosis of multiple diseases using a single device. The ability to interface with smartphones and cloud-based systems enables real-time data sharing and remote patient monitoring. These technological advancements have made POC diagnostics not only suitable for use in hospitals but also in clinics, ambulances, and even at home. Wearable and handheld diagnostic devices are also becoming increasingly popular, enabling continuous health monitoring. Technological advancements have improved the efficiency of POC diagnostic devices, making them more affordable and accessible, which is a major contributor to the growth of the market. February 2024, Roche launched three new coagulation assays for oral Factor Xa inhibitors, rivaroxaban, apixaban, and edoxaban, in regions that accept the CE mark. These new assays may help with clinical decision-making in patients receiving direct oral anticoagulants for systemic embolism, stroke prevention, and venous thromboembolism prevention and treatment.

Growing Demand for Home Healthcare and Decentralized Testing

The rising demand for home healthcare and decentralized medical services is fueling the demand for POC diagnostics. Patients are also preferring convenient and rapid testing solutions that can be conducted at home or at nearby healthcare facilities without the need to visit centralized laboratories. Home-based POC solutions enable patients to test their conditions, such as diabetes, pregnancy, and infections, on their own, which is improving patient engagement and management. This is particularly significant for senior patients, patients with mobility issues, and patients in rural areas. The healthcare infrastructure is also encouraging decentralized testing to alleviate hospital congestion and increase efficiency. The COVID-19 outbreak has fueled the demand for home testing and reinforced the need for rapid and accessible diagnostics. In addition, the integration of telemedicine solutions with POC solutions enables healthcare professionals to remotely track patients. With the evolving healthcare landscape focusing on patient-centric and decentralized care, the demand for POC diagnostics will continue to increase. June 2025, Amazon India announced that it is entering the diagnostics industry by launching a new at-home diagnostics service that allows customers to book lab tests, manage and track appointments, and view digital copies of reports from the Amazon app.

Challenges of the Point of Care Diagnostics Market

Accuracy and Reliability Concerns Compared to Laboratory Testing

One of the biggest challenges in the POC diagnostics market is ensuring accuracy and reliability that is comparable to traditional laboratory testing. Although POC testing is rapid, there may be some tests that lack sensitivity or specificity, resulting in false positives or false negatives. This may impact clinical decisions and patient safety. Differences in device quality, environmental factors, and handling of the devices may also affect the tests. False test results may necessitate additional confirmatory testing in centralized laboratories, thereby increasing healthcare costs and time. It is important to ensure consistent quality and performance of the devices in different healthcare settings. There is a need for investment in research and development to enhance the accuracy and validation of the devices. Additionally, strict quality requirements are imposed by regulatory bodies, which may increase development time and costs.

Regulatory Challenges and Limited Skilled Professionals

The challenge of strict regulatory requirements is a major issue in the development and marketing of POC diagnostic devices. The manufacturers are required to meet the stringent regulatory requirements to ensure the safety, accuracy, and efficacy of the devices. The regulatory requirements may cause delays in the launch of new products. In addition, the regulatory requirements differ from country to country, making it difficult to access the global market. The challenge of a lack of trained healthcare professionals to operate the POC diagnostic devices effectively is another issue. Even though the devices are designed to be user-friendly, training is required to ensure the accuracy of the results and the efficacy of patient care. The lack of awareness and expertise may hinder the adoption of the devices in certain healthcare settings.

Point of Care Infectious Diseases Kits Market

The Point of Care infectious diseases kits are developed to rapidly identify viruses, bacteria, and parasites at or near the point of patient care. The kits enable rapid results, often in a matter of minutes, to allow for timely diagnosis and treatment of infections. The kits are commonly used to diagnose infections such as influenza, COVID-19, HIV, malaria, and dengue fever. The rising incidence of infectious diseases and the need for early detection to avert outbreaks are driving the demand for these kits. The kits are particularly useful in emergency care, rural, and resource-limited laboratory settings. Advances in technology have enhanced the sensitivity and specificity of the kits. Governments and health institutions are encouraging rapid testing to improve disease surveillance and response. As the global spotlight on infection control and preparedness continues to rise, the demand for point of care infectious disease kits is anticipated to rise substantially.

Lateral Flow Point of Care Diagnostics Market

Lateral flow point-of-care diagnostic kits are popular due to their simplicity, affordability, and rapid results. These diagnostic kits rely on a small sample of blood, urine, or saliva, and the results are indicated by a visual marker in a few minutes. Examples of lateral flow point-of-care diagnostic kits include pregnancy tests, COVID-19 rapid antigen tests, and infectious disease test kits. These devices do not require sophisticated laboratory equipment or technical expertise, making them suitable for home use, clinics, or developing regions. The growing need for convenient and rapid testing solutions is fueling the demand for lateral flow diagnostic kits. Advances in technology have improved the sensitivity and accuracy of lateral flow diagnostic kits, and their applications have expanded from clinical to non-clinical settings. Furthermore, the growing awareness of preventive healthcare and self-testing is also fueling the demand for lateral flow diagnostic kits.

Point of Care Prescription-Based Devices Market

Prescription-based point of care devices are advanced diagnostic tools that need authorization from healthcare professionals for their use. These devices are widely used for the diagnosis and management of serious health conditions such as cardiovascular diseases, diabetes, and infectious diseases. Prescription-based point of care devices are highly accurate and are widely used in hospitals, clinics, and healthcare facilities. Prescription-based point of care devices assist healthcare professionals in making instant clinical decisions, thus increasing the efficiency of treatment. The rising incidence of chronic diseases and the growing need for accurate and rapid diagnostic tools are driving the market. Technological advancements have improved the efficiency, portability, and integration of these devices with digital healthcare systems. In addition, regulatory approval has ensured safety, quality, and reliability, thus increasing acceptance among healthcare professionals. With the continued emphasis on early diagnosis and personalized treatment in the healthcare industry, the demand for prescription-based point of care diagnostic devices is expected to rise steadily.

Point of Care Diagnostics Home Care Market

The market for point of care diagnostics home care is growing due to the increasing demand for convenient and accessible healthcare solutions. Home care diagnostic devices enable patients to track their health conditions, such as diabetes, pregnancy, infections, and cardiovascular health, without visiting healthcare facilities. The devices offer quick results, allowing for early detection and effective management of diseases. The rising geriatric population and increasing prevalence of chronic diseases are major drivers of the market. Home care diagnostics lower healthcare expenses, reduce hospital visits, and offer greater patient comfort. Advances in technology have enabled the creation of user-friendly, portable, and accurate devices that are suitable for home use. Moreover, the increasing adoption of telemedicine facilitates remote patient tracking and consultation with the help of home diagnostic devices. With the advent of patient-centered care and preventive healthcare management, the market for point of care diagnostics in home care is anticipated to experience substantial growth globally.

United States Point of Care Diagnostics Market

The United States point of care diagnostics market is well-established because of its advanced healthcare infrastructure and adoption of innovative diagnostic solutions. Hospitals, clinics, and home healthcare services widely use POC devices to enhance diagnostic efficiency and patient care. The high incidence of chronic diseases like diabetes, cardiovascular diseases, and infectious diseases has fueled the demand for rapid and accurate testing solutions. Technological innovations and the presence of key diagnostic device manufacturers in the market enable continuous innovation in portable and digital diagnostic solutions. Furthermore, the rising demand for home healthcare and remote patient monitoring is fueling adoption. Government support, favorable reimbursement policies, and rising awareness about early disease detection also fuel market growth. The integration of POC devices with digital health platforms improves real-time monitoring and clinical decision-making. With the advent of personalized and decentralized healthcare, the United States POC diagnostics market is anticipated to grow substantially. May 2025, Siemens Healthineers strengthened its presence in the United States with a new investment of USD 150 million, improving manufacturing, supply chain resilience, and customer support services through new and renovated facilities in various states.

United Kingdom Point of Care Diagnostics Market

The United Kingdom point of care diagnostics market is growing steadily as a result of the integration of rapid diagnostic solutions within the public healthcare system. Healthcare organizations are increasingly adopting POC testing to enhance diagnostic efficiency and alleviate the burden on centralized laboratories. The growing incidence of chronic and infectious diseases has accelerated the demand for efficient and accurate diagnostic solutions. Hospitals, general practitioners, and community healthcare organizations are increasingly adopting POC devices to improve patient care and alleviate hospital admissions. Technological innovation and the growing focus on preventive healthcare are also driving the market. In addition, the growing geriatric population and the increasing demand for home-based healthcare services are fueling the adoption of portable diagnostic devices. Government initiatives to modernize the healthcare system and integrate digital health solutions further boost the market. With the continued focus on the healthcare system's efficiency and early disease detection, the demand for point of care diagnostics in the United Kingdom is expected to grow steadily.

India Point of Care Diagnostics Market

The Indian point of care diagnostics market is expanding at a fast pace due to the increasing accessibility of healthcare and the need for cost-effective and rapid diagnostic tools. The large number of infectious diseases like tuberculosis, dengue, and malaria, along with the increasing prevalence of chronic diseases like diabetes, is fueling the demand for rapid and accurate testing. POC devices are particularly useful in rural and distant areas where access to centralized labs is not possible. Government efforts to enhance the country's healthcare infrastructure and encourage early disease detection are also boosting demand. In addition, the increasing number of diagnostic labs, hospitals, and home healthcare services is also fueling market growth. Advances in technology and the availability of cost-effective diagnostic tools have made testing more accessible to a larger population. Growing awareness about preventive healthcare and early disease detection is also fueling demand. With its improving healthcare infrastructure, India is set to become a prominent emerging market for point of care diagnostics. January 2023, Cipla launched Cippoint, which is an immunofluorescence-based quantitative analyzer for non-communicable diseases, infectious diseases, and other diseases. The results can be obtained in 3-15 minutes and are suitable for rural settings as well as mobile vans.

Saudi Arabia Point of Care Diagnostics Market

The Saudi Arabian point of care diagnostics market is growing due to the ongoing modernization of the healthcare sector and investments in advanced medical technology. The government is also making efforts to enhance the quality and availability of healthcare, which is boosting the adoption of rapid diagnostic solutions in hospitals and healthcare centers. The growing number of cases of chronic diseases like diabetes and cardiovascular disorders has also raised the need for continuous monitoring and early diagnosis. Point of care diagnostic products enable healthcare professionals to provide patients with faster and more efficient healthcare services. In addition, the growing awareness of preventive healthcare and the need for home-based monitoring solutions are also fueling the market. Oct. 2025, Co-Diagnostics, Inc. announced that it has entered into a definitive agreement with Arabian Eagle Manufacturing to form a joint venture, CoMira Diagnostics, to research, develop, manufacture, assemble, and commercialize the Company's Co-Dx technologies and intellectual properties, including the Company's upcoming Co-Dx PCR point-of-care platform.

Market Segmentation

Products

• Glucose Monitoring Kits
• Infectious Diseases Kits
• Pregnancy & Fertility Testing Kits
• Haematology Testing Kits
• Cardiometabolic Monitoring Kits
• Urinalysis Testing Kits
• Cholesterol Test Strips
• Drugs Abuses Testing Kits
• Others

Technology

• Lateral Flow
• Agitation
• flow through
• solid phase
• biosensor
• Others

Point of prescription

• Prescription-Based Devices
• Over-the-counter (OTC)-Based Devices

End-User

• Professional Diagnostic Centers
• Research Laboratories
• Home Care
• Others

Country - Market breakup of 25 Countries:

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

All the Key players have been covered from 5 Viewpoints:

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis

• Sysmex
• Abbott Laboratories (US)
• Becton Dickinson and Company (US)
• Danaher Corporation (US)
• Quidel Diagnostics (US)
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.